IDH1 Development

dmercer1 Member Posts: 16


  • I_Promise
    I_Promise Member Posts: 218 Member
    Thank you

    for sharing this info. I had not seen it. What is interesting is that the drug used 5-azacytidine is already an FDA approved drug for other cancers. So I guess an oncologist could always prescribe it off label if she/he wanted to... Of course you need to carry the mutation IDH1 mutation (present in 70-80% of low grade gliomas) to use this new drug. I hope they fast forward a clinical trial.